4//SEC Filing
O'Brien Anthony Stephen 4
Accession 0001618835-22-000107
CIK 0001618835other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:10 PM ET
Size
5.9 KB
Accession
0001618835-22-000107
Insider Transaction Report
Form 4
O'Brien Anthony Stephen
Director
Transactions
- Award
Stock option (right to buy)
2022-05-04+6,000→ 6,000 totalExercise: $2.47Exp: 2032-05-04→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022.
- [F2]The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Mr. O'Brien's board and committee services.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726732
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:10 PM ET
- Size
- 5.9 KB